Please login to the form below

Not currently logged in
Email:
Password:

MHLW

This page shows the latest MHLW news and features for those working in and with pharma, biotech and healthcare.

Bayer roll-out of haemophilia drug Jivi gathers pace

Bayer roll-out of haemophilia drug Jivi gathers pace

Japan’s MHLW is next to approve the drug. Bayer has added another big market for its new haemophilia A product Jivi, adding approval in Japan to a green light in ... Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Jivi (damoctocog

Latest news

  • MSD’s Keytruda wins bladder cancer indication in Japan MSD’s Keytruda wins bladder cancer indication in Japan

    Bladder cancer patients living in Japan can now access Merck Sharp and Dohme’s (MSD) Keytruda (pembrolizumab) following a green light from the Japanese Ministry of Health, Labour and Welfare (MHLW).

  • Ono faces steep price cut for Opdivo in Japan Ono faces steep price cut for Opdivo in Japan

    The MHLW committee has accelerated that process by activating an emergency provision that allows earlier cuts for big-selling drugs – making 100bn to 150bn yen a year – and which exceed company

  • Japanese approvals for GSK, AZ and Bayer Japanese approvals for GSK, AZ and Bayer

    MHLW gives Nucala, Tagrisso and Xofigo the green light. Japan's drug regulator has approved a flurry of new medicines, including GlaxoSmithKline's asthma therapy Nucala and cancer drugs from AstraZeneca ... The Ministry of Health, Labour and Welfare (MHLW

  • Takeda's once-weekly DPP-4 inhibitor cleared in first market Takeda's once-weekly DPP-4 inhibitor cleared in first market

    GlaxoSmithKline (GSK) has been given the go-ahead by the MHLW to market its long-acting muscarinic antagonist (LAMA) Encruse (umeclidinium) for chronic obstructive pulmonary disease (COPD). ... Amgen/Astellas' PCSK9-targeting antibody Repatha (evolocumab)

  • Novartis' Japanese subsidiary threatened with suspension Novartis' Japanese subsidiary threatened with suspension

    The company is staying tight-lipped about the reasons for the unusual action by the Ministry Of Health, Labour and Welfare (MHLW), although it has confirmed it has received a

More from news
Approximately 2 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Country report: The healthcare market in Japan Country report: The healthcare market in Japan

    Ministry of Health, Labour and Welfare (MHLW) data revealed that the largest single cause of death was cancer, followed by stroke and heart disease. ... Additionally, if sales of a new drug are greater than estimated by the manufacturer, then its price

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics